Hakutulokset - Kazumi Ito

  • Näytetään 1 - 7 yhteensä 7 tuloksesta
Tarkenna hakua
  1. 1
    Negative regulation of catalase gene expression in hepatoma cells.

    Negative regulation of catalase gene expression in hepatoma cells. Tekijä Kei Sato, Kazumi Ito, Hiromi Kohara, Y Yamaguchi, Kaori Adachi, H. Endo

    Julkaistu 1992
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Novel Assays for Detection of Urinary KIM-1 in Mouse Models of Kidney Injury

    Novel Assays for Detection of Urinary KIM-1 in Mouse Models of Kidney Injury Tekijä Venkata Sabbisetti, Kazumi Ito, Chang Wang, Li Yang, Stephen C. Mefferd, Joseph V. Bonventre

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Histamine H<sub>1</sub> receptor occupancy in human brains after single oral doses of histamine H<sub>1</sub> antagonists measured by positron emission tomography

    Histamine H<sub>1</sub> receptor occupancy in human brains after single oral doses of histamine H<sub>1</sub> antagonists measured by positron emission tomography Tekijä Kazuhiko Yanai, Jong Hoon Ryu, Takehiko Watanabe, Ren Iwata, Tatsuo Ido, Yoneichi Sawai, Kazumi Ito, Masatoshi Itoh

    Julkaistu 1995
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Attractin/Mahogany/Zitter plays a critical role in myelination of the central nervous system

    Attractin/Mahogany/Zitter plays a critical role in myelination of the central nervous system Tekijä Takashi Kuramoto, Kazuhiro Kitada, Toshihide Inui, Yoshifumi Sasaki, Kazumi Ito, Takao Hase, Saburo Kawagachi, Yoshihiro Ogawa, Kazuwa Nakao, Gregory S. Barsh, Minako Nagao, Toshikazu Ushijima, Tadao Serikawa

    Julkaistu 2001
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes

    Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes Tekijä Venkata Sabbisetti, Sushrut S. Waikar, Daniel J. Antoine, Adam M. Smiles, Chang Wang, Abinaya Ravisankar, Kazumi Ito, Sahil Sharma, Swetha Ramadesikan, Michelle Lee, Rebeccah Briskin, Philip L. De Jager, Thanh Thu Ngo, Mark Radlinski, James W. Dear, Kevin B. Park, Rebecca A. Betensky, Andrzej S. Królewski, Joseph V. Bonventre

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Mechanisms of action and resistance in histone methylation-targeted therapy

    Mechanisms of action and resistance in histone methylation-targeted therapy Tekijä Makoto YAMAGISHI, Yuta Kuze, Seiichiro Kobayashi, Makoto Nakashima, Satoko Morishima, Toyotaka Kawamata, Junya Makiyama, Kako Suzuki, Masahide Seki, Kazumi Abe, Kiyomi Imamura, Eri Watanabe, Kazumi Tsuchiya, Isao Yasumatsu, Gensuke Takayama, Yoshiyuki Hizukuri, Kazumi Ito, Yukihiro Taira, Yasuhito Nannya, Arinobu Tojo, Toshiki Watanabe, Shinji Tsutsumi, Yutaka Suzuki, Kaoru Uchimaru

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas

    The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas Tekijä Atsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, Kazuhiko Sugiyama, Nobuhiro Hata, Yoshihiro Muragaki, Naoki Shinojima, Toshihiro Kumabe, Ryuta Saito, Kazuya Motomura, Yohei Mineharu, Yasuji Miyakita, Fumiyuki Yamasaki, Yuko Matsushita, Koichi Ichimura, Kazumi Ito, Masaya Tachibana, Yasuyuki Kakurai, Naoko Okamoto, Takashi Asahi, Soichiro Nishijima, Tomoyuki Yamaguchi, Hiroshi Tsubouchi, Hideo Nakamura, Ryo Nishikawa

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: